SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Nome Químico: (2S,3S,4S,5R,6S)-6-(((S)-2-(3-(((2S,3R,4S,5S,6S)-6-Carboxy-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-4-methoxyphenyl)-5-hydroxy-4-oxochroman-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
Sinônimo: (S)-Hesperetin 3’,7-Diglucuronide
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Sorrisos: O=C1C(C(O[C@H](C(C=C2)=CC(O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]([C@H]3O)C(O)=O)=C2OC)C1)=CC(O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]([C@H]4O)C(O)=O)=C5)=C5O
Hesperetin 3',7-Di-O-β-D-Glucuronide is chemically (2S,3S,4S,5R,6S)-6-(((S)-2-(3-(((2S,3R,4S,5S,6S)-6-Carboxy-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-4-methoxyphenyl)-5-hydroxy-4-oxochroman-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid. It is also known as (S)-Hesperetin 3’,7-Diglucuronide. Hesperetin 3',7-Di-O-β-D-Glucuronide is supplied with detailed characterization data compliant with regulatory guideline. Hesperetin 3',7-Di-O-β-D-Glucuronide can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Hesperetin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Preparation, characterization and application of molecularly 8 imprinted monolithic column for hesperetin
HuikaiShaoa1LingguoZhaob1JianChenbHaitaoZhoubShutingHuangaKangLi
Journal of Pharmaceutical and Biomedical Analysis Volume 111, 10 July 2015, Pages 241-247
An Improved Conversion of Hesperidin into Hesperetin Including Purity Determination by Gradient-Elution, High-pressure Liquid Chromatography
C. Thomas Seitz and Robert E. Wingard Jr.
J. Agric. Food Chem. 1978, 26, 1, 278–280
Oral Bioavailability and Pharmacodynamic Activity of Hesperetin Nanocrystals Generated Using a Novel Bottom-up Technology
Ganesh Shete, Yogesh B. Pawar,Kaushik Thanki, Sanyog Jain, and Arvind Kumar Bansal
Mol. Pharmaceutics 2015, 12, 1158−1170
Validation of RP-HPLC Method for Simultaneous Quantification of Bicalutamide and Hesperetin in Polycaprolactone-Bicalutamide-Hesperetin-Chitosan Nanoparticles
Abhishek Arya, Kiran Khandelwal, Aanchal Singh, Hafsa Ahmad, Satish Agrawal, Renuka Khatik, Naresh Mittapelly, Anil Kumar Dwivedi
Journal of Chromatographic Science, Volume 53, Issue 9, October 2015, Pages 1485–1490